Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma;Langtidseffekter etter kappefeltsbehandling for Hodgkins lymfom

Tidsskrift for den Norske Laegeforening

Volumn 125, Issue 1, 2005, Pages 41-44

  Fosså, Sophie D ^a   Holte, Harald ^a   Holmen, Marit Muri ^a   Bjøro, Trine ^a   Langmark, Frøydis ^a   Hess, Siri Lothe ^a   Kvaløy, Stein ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MANTLE FIELD RADIOTHERAPY; RADIATION CARCINOGENESIS; RISK ASSESSMENT; BREAST TUMOR; HEALTH STATUS; QUESTIONNAIRE; RADIATION INJURY; RADIOTHERAPY; RISK FACTOR; SURVIVOR; TIME;

ADULT; BREAST NEOPLASMS; FEMALE; HEALTH STATUS; HODGKIN DISEASE; HUMANS; NEOPLASMS, RADIATION-INDUCED; QUESTIONNAIRES; RADIOTHERAPY; RISK FACTORS; SURVIVORS; TIME FACTORS;

EID: 13744254977     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Anonymous Cancer in Norway 2000. Det Norske Kreftregisteret, 2002.
2. Lund MB, Kongerud J, Nome O et al. Lung function impairment in long-term survivors of Hodgkin's disease. Ann Oncol 1995; 6: 495-501.
3. Lund MB, Ihlen H, Voss BM et al. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. Heart 1996; 75: 591-5.
4. Foss-Abrahamsen A, Egeland T, Hansen S et al. Hodgkin's disease in a national and hospital population: trends over 20 years. Eur J Cancer 1997; 33: 2380-3.
5. Abrahamsen AF, Loge JH, Hannisdal E et al. Late medical sequelae after therapy for supradiaphragmatic Hodgkin's disease. Acta Oncol 1999; 38: 511-5.
6. Abrahamsen AF, Loge JH, Hannisdal E et al. Socio-medical situation for long-term survivors of Hodgkin's disease: a survey of 459 patients treated at one institution. Eur J Cancer 1998; 34: 1865-70.
7. Foss-Abrahamsen A, Andersen A, Nome O et al. Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time. Ann Oncol 2002; 13: 1786-91.
8. Loge JH, Abrahamsen AF, Ekeberg O et al. Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol 1999; 17: 253-61.
9. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 2001; 325: 599-605.
10. Travis LB, Hill DA, Dores GM et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003; 290: 465-75.
11. Holmen J, Midthjell K, Krüger OØ et al. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): Objectives, contents, methods and participation. Norsk Epidemiologi 2003; 13: 19-32.
12. Johansson AS, Erlanson M, Lenner P et al. Ofta sena biverkningar av Hodgkinbehandling. Muskelatrofi förbisedd risk efter radioterapi. Läkartidningen 1998; 95: 44-7.